179 related articles for article (PubMed ID: 10853882)
1. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
Telatyńska B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol J Pharmacol; 2003; 55(1):81-9. PubMed ID: 12856830
[TBL] [Abstract][Full Text] [Related]
4. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
Telatyńska-Smieszek B
Ann Acad Med Stetin; 2002; 48():367-80. PubMed ID: 14601489
[TBL] [Abstract][Full Text] [Related]
6. Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.
Carmona MJ; Pereira VA; Malbouisson LM; Auler JO; Santos SR
Braz J Med Biol Res; 2009 Jun; 42(6):574-81. PubMed ID: 19448909
[TBL] [Abstract][Full Text] [Related]
7. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
J Clin Pharmacol; 1993 Aug; 33(8):756-61. PubMed ID: 8408738
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of two tablet formulations of atenolol after single oral administration in healthy volunteers.
Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N; Njau SN
Arzneimittelforschung; 2000 Mar; 50(3):243-7. PubMed ID: 10758775
[TBL] [Abstract][Full Text] [Related]
9. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
[TBL] [Abstract][Full Text] [Related]
10. Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
van Baak MA; Mooij JM; Schiffers PM
Eur J Clin Pharmacol; 1992; 43(5):547-50. PubMed ID: 1483493
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
[TBL] [Abstract][Full Text] [Related]
12. Effects of orange juice on the pharmacokinetics of atenolol.
Lilja JJ; Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):337-40. PubMed ID: 15983823
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of two brands of atenolol following a single oral administration.
Irshaid YM; Rawashdeh NM; Awwadi FF; Kato MK
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):457-61. PubMed ID: 8897086
[TBL] [Abstract][Full Text] [Related]
14. Effect of itraconazole on the pharmacokinetics of atenolol.
Lilja JJ; Backman JT; Neuvonen PJ
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
[TBL] [Abstract][Full Text] [Related]
15. Influence of cardiopulmonary bypass on the plasma concentrations of atenolol.
Leite Fda S; dos Santos LM; Bonafé WW; Chignalia AZ; Carmona MJ; Suyama MJ; Malbouisson LM; Auler JO; Santos SR
Arq Bras Cardiol; 2007 Jun; 88(6):637-42. PubMed ID: 17664990
[TBL] [Abstract][Full Text] [Related]
16. Effect of unilateral nephrectomy on the pharmacokinetics of atenolol in humans.
Drozdzik M; Domanski L; Wojcicki J; Pudlo A; Machoy P
J Clin Pharmacol; 2003 May; 43(5):524-8. PubMed ID: 12751273
[TBL] [Abstract][Full Text] [Related]
17. The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults.
Panton LB; Guillen GJ; Williams L; Graves JE; Vivas C; Cediel M; Pollock ML; Garzarella L; Krumerman J; Derendorf H
J Clin Pharmacol; 1995 Sep; 35(9):885-94. PubMed ID: 8786248
[TBL] [Abstract][Full Text] [Related]
18. Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers.
Weber C; Tam YK; Schmidtke-Schrezenmeier G; Jonkmann JH; van Brummelen P
Eur J Clin Pharmacol; 1996; 51(1):87-90. PubMed ID: 8880057
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine.
Dieterle W; Corynen S; Vaidyanathan S; Mann J
Int J Clin Pharmacol Ther; 2005 Nov; 43(11):527-35. PubMed ID: 16300168
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
Czendlik CH; Sioufi A; Preiswerk G; Howald H
Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
